{
"@context": "https://schema.org",
"@type": "Article",
"headline": "UK Public Procurement Landscape Transformed: What Does It Mean for Medicines?",
"url": "https://www.lexblog.com/2025/03/27/uk-public-procurement-landscape-transformed-what-does-it-mean-for-medicines/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-29VB551G",
"url": "https://www.lexblog.com/lib/29VB551G/"
},
"datePublished": "2025-03-27T08:08:08-04:00",
"dateModified": "2026-02-25T11:39:43-05:00",
"author": {
"@type": "Person",
"name": "Heba Jalil, Arnold & Porter"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Arnold & Porter Kaye Scholer LLP"
},
"organizationScope": "at-publication",
"isPartOf": "BioSlice Blog",
"about": "Administrative and Regulatory ยท Government Contracts",
"sourceUrl": "https://www.biosliceblog.com/?p=3703",
"sourceStability": "may-move"
}